Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01458522 · ClinicalTrials.gov registry record · Phase 2
Intravenous Lacosamide Compared With Fosphenytoin in the Treatment of Patients With Frequent Nonconvulsive Seizures
A Phase 2 study of Nonconvulsive Seizures, sponsored by Aatif Husain.
- Completed
- Registry status
- Phase 2
- Development phase
- 74
- Enrollment target
- 11
- Study locations
NCT01458522 is a Phase 2 study of Nonconvulsive Seizures that has completed, run by Aatif Husain. The registered enrollment target is 74 participants. The trial reports 11 study locations across 8 states.
The verdict
NCT01458522, a Phase 2 study of Nonconvulsive Seizures, has completed, sponsored by Aatif Husain.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 74 participants
- Enrollment target
- 11
- Study locations
Study Summary
This a phase 2 study comparing the efficacy of intravenous (IV) lacosamide (LCM) with IV fosphenytoin (fPHT) in controlling frequent nonconvulsive seizures (NCSs), the Adverse Events profile of LCM compared with fPHT when used to treat frequent NCSs, and length of stay in an intensive care unit for subjects treated with LCM versus subjects treated with fPHT. The trial will include a preacute-treatment period, an acute-treatment period, a postacute-treatment period, and a long-term follow-up period.
Conditions Studied
Interventions
- DRUG fPHT
- DRUG LCM
Study Locations (11)
Massachusetts
- Massachusetts General Hospital - Boston
- Beth Israel Deaconess Medical Center - Boston
- Brigham and Woman's Hospital - Boston
North Carolina
- Mission Hospital - Asheville
- Duke University Medical Center - Durham
California
- Huntington Memorial Hospital - Pasadena
Connecticut
- Yale University School of Medicine - New Haven
Georgia
- Emory University School of Medicine - Atlanta
South Carolina
- Medical University of South Carolina - Charleston
Tennessee
- Vanderbilt University Medical Center - Nashville
Texas
- University of Texas Southwestern Medical Center Dallas - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2012-05 |
| Est. Completion | 2015-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01458522
The ClinicalTrials.gov registry entry for NCT01458522 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Aatif Husain, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nonconvulsive Seizures appearing as the primary indexed condition, and to 2 interventions - of which fPHT is the first listed.
NCT01458522 reports 11 study locations spanning 8 distinct geographic areas - top geographies include Massachusetts, North Carolina, California.
Frequently Asked Questions
What is clinical trial NCT01458522 about?
NCT01458522 is a clinical study titled "Intravenous Lacosamide Compared With Fosphenytoin in the Treatment of Patients With Frequent Nonconvulsive Seizures". This a phase 2 study comparing the efficacy of intravenous (IV) lacosamide (LCM) with IV fosphenytoin (fPHT) in controlling frequent nonconvulsive seizures (NCSs), the Adverse Events profile of LCM compared with fPHT when used to treat frequent NCSs, and length of stay in an intensive care unit for ...
What is the current status of trial NCT01458522?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 74 participants. The study started on 2012-05. Estimated completion is 2015-07.
What conditions does trial NCT01458522 study?
This clinical trial studies the following conditions: Nonconvulsive Seizures.
What interventions are being tested in trial NCT01458522?
The interventions under investigation include: fPHT (DRUG), LCM (DRUG).
Who is sponsoring clinical trial NCT01458522?
This trial is sponsored by Aatif Husain, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01458522 being conducted?
This trial has 11 study locations across California, Connecticut, Georgia, Massachusetts, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nonconvulsive Seizures
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.